SCHEMBL29822193

SCHEMBL29822193

CCOC(=O)NC(=O)C(C#N)=NNc1cc(Cl)c(Oc2ccc(=O)n(Cc3ccc(C)cc3)c2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ ALOX12 P18054 3/20 0.52
▸ THRB P10828 3/20 0.48
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ RAPGEF3 O95398 3/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MAPT P10636 5/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ P2RX3 P56373 2/20 0.34
▸ THRA P10827 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29821950 0.95 MEN1 (0.51) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821836 0.94 THRB (0.57) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821504 0.94 MEN1 (0.52) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL30151623 0.92 MEN1 (0.51) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821968 0.92 ALOX12 (0.40) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29822031 0.92 MEN1 (0.51) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821960 0.92 ALOX12 (0.49) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821951 0.90 MEN1 (0.48) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821730 0.89 MEN1 (0.54) MEN1KMT2AALOX12THRBALDH1A1
SCHEMBL29821403 0.89 KMT2A (0.54) MEN1KMT2AALOX12THRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-05-05 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
EP-4036090-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA MEN1 891/4885KMT2A 2737/4885ALOX12 560/4885
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof THRB, TSHR, THRA MEN1 2442/4885KMT2A 4017/4885ALOX12 925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback